* Ekso Bionics Holdings Inc EKSO.OQ EKSO.O is expected
to show
a rise in quarterly revenue when it reports results on July
28.
* The Richmond California California-based company is
expected to
report a 58.0% increase in revenue to $3.494 million from $2.21
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Ekso Bionics
Holdings Inc
is for a loss of 24 cents per share. For the same quarter last
year, the company reported a loss of 19 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $11, above its last closing price of $1.64.
This summary was machine generated July 27 at 02:04 GMT. All
figures in US dollars unless otherwise stated